Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$379M |
| 2 |
Starbucks
SBUX
|
+$371M |
| 3 |
APC
Anadarko Petroleum
APC
|
+$287M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$263M |
| 5 |
Tesla
TSLA
|
+$253M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortive
FTV
|
+$1.27B |
| 2 |
ANDV
Andeavor
ANDV
|
+$1.11B |
| 3 |
AET
Aetna Inc
AET
|
+$535M |
| 4 |
Microsoft
MSFT
|
+$350M |
| 5 |
Amazon
AMZN
|
+$290M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.69% |
| 2 | Technology | 13.64% |
| 3 | Financials | 12.49% |
| 4 | Consumer Discretionary | 10.83% |
| 5 | Industrials | 9.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
Nokia
NOK
$55.6B
| $56.1M | 0.09% |
9,639,023
+8,591,749
| +820% | +$48.2M |
|
302
BP
BP
$113B
| $56M | 0.09% |
1,524,784
-999,761
| -40% | -$39.9M |
|
303
International Paper
IP
$21.7B
| $55.7M | 0.09% |
1,456,850
+1,069,580
| +276% | +$44.9M |
|
304
iShares MSCI Taiwan ETF
EWT
$11.2B
| $55.6M | 0.09% |
1,758,586
+1,338,301
| +318% | +$44.5M |
|
305
Westlake Corp
WLK
$9.74B
| $55.2M | 0.09% |
834,024
+422,380
| +103% | +$30.5M |
|
306
CALL
Alphabet (Google) Class A
GOOGL
$4.26T
| $55.2M | 0.09% |
1,056,000
+640,000
| +154% | +$34.6M |
|
307
Micron Technology
MU
$1.03T
| $55.1M | 0.09% |
1,735,447
+1,723,655
| +14,617% | +$65.3M |
|
308
PUT
Qualcomm
QCOM
$167B
| $55M | 0.09% |
966,300
+717,500
| +288% | +$43.6M |
|
309
East-West Bancorp
EWBC
$17.7B
| $54.7M | 0.09% |
1,256,633
+553,961
| +79% | +$28.7M |
|
310
FedEx
FDX
$77.9B
| $54.4M | 0.08% |
337,082
+203,086
| +152% | +$43M |
|
311
Adobe
ADBE
$110B
| $54.3M | 0.08% |
239,840
-4,456
| -2% | -$1.08M |
|
312
Darden Restaurants
DRI
$25.6B
| $53.8M | 0.08% |
539,124
+197,092
| +58% | +$21.1M |
|
|
HOLX
313
DELISTED
Hologic
HOLX
| $53.7M | 0.08% |
1,307,027
+586,248
| +81% | +$24M |
|
314
Chubb
CB
$133B
| $53.6M | 0.08% |
414,994
+305,108
| +278% | +$39.4M |
|
315
Sysco
SYY
$40.3B
| $53.5M | 0.08% |
854,338
-196,560
| -19% | -$13.3M |
|
316
Dell
DELL
$281B
| $53.5M | 0.08% |
2,161,216
+1,560,141
| +260% | +$42.7M |
|
|
NBL
317
DELISTED
Noble Energy, Inc.
NBL
| $53.4M | 0.08% |
2,844,076
+2,494,948
| +715% | +$63.8M |
|
318
State Street SPDR Bloomberg High Yield Bond ETF
JNK
$6.67B
| $53.3M | 0.08% |
529,347
+425,139
| +408% | +$44.4M |
|
319
ON Semiconductor
ON
$28B
| $53.1M | 0.08% |
3,215,704
+3,056,275
| +1,917% | +$52.9M |
|
|
WBA
320
DELISTED
Walgreens Boots Alliance
WBA
| $53M | 0.08% |
775,692
+744,026
| +2,350% | +$57.7M |
|
321
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$17.6B
| $52.9M | 0.08% |
652,130
+582,707
| +839% | +$48.8M |
|
322
Vulcan Materials
VMC
$35.6B
| $52.8M | 0.08% |
534,618
-337,361
| -39% | -$34.2M |
|
323
Pacira BioSciences
PCRX
$990M
| $52.7M | 0.08% |
1,224,514
-204,456
| -14% | -$9.54M |
|
324
Lockheed Martin
LMT
$130B
| $52.3M | 0.08% |
199,851
+973
| +0.5% | +$295K |
|
325
PUT
iShares Biotechnology ETF
IBB
$10.7B
| $52.2M | 0.08% |
541,200
-66,400
| -11% | -$7.05M |
|
Similar funds
Israel Englander's Q4 2018 Portfolio in Review
As of Q4 2018, Israel Englander held 4,541 positions worth $64.1B, down 21% from $81.6B the previous quarter. Its ten largest holdings account for 6.7% of the portfolio.
Israel Englander withdrew a net $4.25B in Q4 2018, closing 844 positions and reducing 1,571 holdings. Its most notable exit was Andeavor, an estimated $1.11B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 12% a quarter earlier, followed by Technology and Financials.
Against the trend, Israel Englander opened a new position in Athenahealth, Inc. worth $135M.
- Israel Englander's largest Q4 2018 buy was Athenahealth, Inc.: 1,022,505 shares worth $135M.
- Israel Englander added most to Celgene Corp in Q4 2018, an estimated $379M increase.
- Israel Englander's biggest Q4 2018 reduction was Fortive, cutting an estimated $1.27B.
- Israel Englander fully exited Andeavor in Q4 2018, selling an estimated $1.11B.
- Israel Englander's ten largest holdings make up 6.7% of its $64.1B portfolio in Q4 2018.
- Israel Englander opened 702 new positions and closed 844 in Q4 2018.
- Israel Englander's portfolio value fell 21% quarter-over-quarter to $64.1B.
Based on Millennium Management's 13F filing for Q4 2018, filed 14 Feb 2019.